Genes
NCBI Gene
One gene with its proteins, patents, drugs, trials, grants and papers.
85,013 comparisons from ClinicalTrials.gov. Counted 2026-11-10.
Most participants first33,758 with no events in either group come last1,321 to 1,340 of 85,013
| Comparison | With the outcome | Risk difference, 95% interval | Participants | Trial |
|---|---|---|---|---|
| Chronic HF Without SDB vs Chronic HF With SDB: Nocturnal Dyspnea | 672 of 3,686 800 of 3,190 | -6.8 points -8.8 to -4.9 | 6,876 | NCT01500759 Sleep-Disordered Breathing in Heart Failure - The SchlaHF-Registry |
| Patients With Chronic HF Without SDB Male vs Patients With Chronic Heart Failure and SDB Male: Male Gender as Predictor for SDB in Chronic HF | 2,754 of 3,686 2,674 of 3,190 | -9.1 points -11.0 to -7.2 | 6,876 | NCT01500759 Sleep-Disordered Breathing in Heart Failure - The SchlaHF-Registry |
| Patients With Chronic HF Without SDB and Ischemic Etiology vs Patients With Chronic Heart Failure and SDB and Ischemic Etiol: Ischemic Etiology as Predictor for SDB in Chronic HF | 1,961 of 3,686 1,742 of 3,190 | -1.4 points -3.8 to 1.0 | 6,876 | NCT01500759 Sleep-Disordered Breathing in Heart Failure - The SchlaHF-Registry |
| Chronic HF Without SDB vs Chronic HF With SDB: Aldosterone Antagonists | 1,808 of 3,686 1,454 of 3,190 | 3.5 points 1.1 to 5.8 | 6,876 | NCT01500759 Sleep-Disordered Breathing in Heart Failure - The SchlaHF-Registry |
| Patients With Chronic HF Without SDB and AF vs Patients With Chronic Heart Failure and SDB and AF: Atrial Fibrillation (AF) as a Predictor for SDB in Chronic HF | 863 of 3,686 1,001 of 3,190 | -8.0 points -10.1 to -5.9 | 6,876 | NCT01500759 Sleep-Disordered Breathing in Heart Failure - The SchlaHF-Registry |
| Chronic HF Without SDB vs Chronic HF With SDB: Beta-blocker | 3,284 of 3,686 2,824 of 3,190 | 0.6 points -0.9 to 2.1 | 6,876 | NCT01500759 Sleep-Disordered Breathing in Heart Failure - The SchlaHF-Registry |
| Chronic HF Without SDB vs Chronic HF With SDB: Atrial Fibrillation | 863 of 3,686 1,001 of 3,190 | -8.0 points -10.1 to -5.9 | 6,876 | NCT01500759 Sleep-Disordered Breathing in Heart Failure - The SchlaHF-Registry |
| Chronic HF Without SDB vs Chronic HF With SDB: Medication ACE Inhibitors and/ARBs | 3,269 of 3,686 2,812 of 3,190 | 0.5 points -1.0 to 2.1 | 6,876 | NCT01500759 Sleep-Disordered Breathing in Heart Failure - The SchlaHF-Registry |
| Chronic HF Without SDB vs Chronic HF With SDB: Diuretics | 2,805 of 3,686 2,617 of 3,190 | -5.9 points -7.8 to -4.0 | 6,876 | NCT01500759 Sleep-Disordered Breathing in Heart Failure - The SchlaHF-Registry |
| Chronic HF Without SDB vs Chronic HF With SDB: Male Gender | 2,754 of 3,686 2,674 of 3,190 | -9.1 points -11.0 to -7.2 | 6,876 | NCT01500759 Sleep-Disordered Breathing in Heart Failure - The SchlaHF-Registry |
| Chronic HF Without SDB vs Chronic HF With SDB: Nocturia ≥3 Times/Night | 580 of 3,686 660 of 3,190 | -5.0 points -6.8 to -3.1 | 6,876 | NCT01500759 Sleep-Disordered Breathing in Heart Failure - The SchlaHF-Registry |
| Nesiritide vs Placebo: Composite of Cardiovascular Rehospitalization and Cardiovascular Mortality | 372 of 3,423 402 of 3,415 | -0.9 points -2.4 to 0.6 | 6,838 | NCT00475852 A Study Testing the Effectiveness of Nesiritide in Patients With Acute Decompensated Heart Failure |
| Nesiritide vs Placebo: Composite of Rehospitalization Due to Heart Failure and All-Cause Mortality | 321 of 3,423 345 of 3,413 | -0.7 points -2.1 to 0.7 | 6,836 | NCT00475852 A Study Testing the Effectiveness of Nesiritide in Patients With Acute Decompensated Heart Failure |
| Vaccinated vs Unvaccinated: Across Years, Estimate the Difference in Carriage Prevalence of N. Meningitidis Genogroups Causing Disease (A, B, C, W, X, Y) Between South Australian School Leavers Who Received 4CMenB Vaccine and Unvaccinated Students | 200 of 3,885 159 of 2,909 | -0.3 points -1.4 to 0.7 | 6,794 | NCT03419533 Study to Assess Oropharyngeal Carriage of N. Meningitidis in South Australian School Leavers |
| 2018 School Leavers vs 2019 School Leavers: Estimate the Difference in Carriage Prevalence of Disease Associated Genogroups of N. Meningitidis (A, B, C, W, X, Y) Between School Leavers in 2018 (Year 12 in 2017) and 2019 (Year 12 in 2018), Following a 4CMenB School Immunisation Program | 225 of 4,104 134 of 2,690 | 0.5 points -0.6 to 1.6 | 6,794 | NCT03419533 Study to Assess Oropharyngeal Carriage of N. Meningitidis in South Australian School Leavers |
| 2018 School Leavers vs 2019 School Leavers: Estimate the Difference in Carriage Prevalence of All N. Meningitidis Genogroups Between South Australian School Leavers in 2018 (Year 12 in 2017) and 2019 (Year 12 in 2018) | 393 of 4,104 227 of 2,690 | 1.1 points -0.3 to 2.5 | 6,794 | NCT03419533 Study to Assess Oropharyngeal Carriage of N. Meningitidis in South Australian School Leavers |
| Vaccinated vs Unvaccinated: Across Years, Estimate the Difference in Carriage Prevalence of All N. Meningitidis Genogroups Between South Australian School Leavers Who Have Received 4CMenB and Unvaccinated Students. | 339 of 3,885 281 of 2,909 | -0.9 points -2.3 to 0.4 | 6,794 | NCT03419533 Study to Assess Oropharyngeal Carriage of N. Meningitidis in South Australian School Leavers |
| Intensive Glycemic Control vs Standard Glycemic Control: Number of Participants With at Least One Fall | 1,122 of 3,364 1,133 of 3,418 | 0.2 points -2.0 to 2.4 | 6,782 | NCT00324350 Intensive Glycemic Control and Skeletal Health Study |
| Male vs Female: Identify Characteristics Associated With Carriage Prevalence of N. Meningitidis Genogroups Causing Disease (A, B, C, W, X, Y) in South Australian School Leavers in 2018 /2019 | 154 of 2,709 204 of 4,055 | 0.7 points -0.4 to 1.8 | 6,764 | NCT03419533 Study to Assess Oropharyngeal Carriage of N. Meningitidis in South Australian School Leavers |
| Male vs Female: Identify Characteristics Associated With Carriage Prevalence of All N. Meningitidis Genogroups in South Australian School Leavers in 2018/2019 | 268 of 2,709 350 of 4,055 | 1.3 points -0.1 to 2.7 | 6,764 | NCT03419533 Study to Assess Oropharyngeal Carriage of N. Meningitidis in South Australian School Leavers |
Response
The first 2 of this page's 20 results. GET /api/comparisons/v1?page=67
{
"data": {
"total": 85013,
"results": [
{
"id": "NCT01500759-2f241d51",
"title": "Chronic HF Without SDB vs Chronic HF With SDB: Nocturnal Dyspnea",
"summary": "672 of 3686 against 800 of 3190; risk difference -6.8 points, 95% interval -8.8 to -4.9; NCT01500759, Sleep-Disordered Breathing in Heart Failure - The SchlaHF-Registry",
"record": "/library/comparisons/NCT01500759-2f241d51",
"nct_id": "NCT01500759",
"kind": "outcome",
"participants": 6876,
"risk_difference": {
"value": -0.06847225033465607,
"lower": -0.0880262393309323,
"upper": -0.04895770134317816
},
"group_1": "672 of 3,686",
"group_2": "800 of 3,190",
"difference": "-6.8 points",
"interval": "-8.8 to -4.9",
"trial_title": "Sleep-Disordered Breathing in Heart Failure - The SchlaHF-Registry"
},
{
"id": "NCT01500759-3d1713cb",
"title": "Patients With Chronic HF Without SDB Male vs Patients With Chronic Heart Failure and SDB Male: Male Gender as Predictor for SDB in Chronic HF",
"summary": "2754 of 3686 against 2674 of 3190; risk difference -9.1 points, 95% interval -11.0 to -7.2; NCT01500759, Sleep-Disordered Breathing in Heart Failure - The SchlaHF-Registry",
"record": "/library/comparisons/NCT01500759-3d1713cb",
"nct_id": "NCT01500759",
"kind": "outcome",
"participants": 6876,
"risk_difference": {
"value": -0.09109313049290968,
"lower": -0.10998886875480489,
"upper": -0.07202995764214573
},
"group_1": "2,754 of 3,686",
"group_2": "2,674 of 3,190",
"difference": "-9.1 points",
"interval": "-11.0 to -7.2",
"trial_title": "Sleep-Disordered Breathing in Heart Failure - The SchlaHF-Registry"
}
],
"no_events": 33758,
"columns": [
{
"key": "title",
"label": "Comparison"
},
{
"key": "group_1",
"label": "With the outcome",
"under": "group_2"
},
{
"key": "difference",
"label": "Risk difference, 95% interval",
"under": "interval"
},
{
"key": "participants",
"label": "Participants"
},
{
"key": "nct_id",
"label": "Trial",
"under": "trial_title"
}
],
"order": "Most participants first",
"kinds": {
"all": 85013,
"outcome": 33568,
"serious-adverse-events": 31897,
"deaths": 19548
}
},
"release": "trial-comparisons-2026-03-23-0.1.0",
"terms": [
{
"source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
"license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
"short": "Freely available. Acknowledgement requested"
},
{
"source": "ClinicalTrials.gov",
"license": "none stated",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
"short": "None stated"
}
],
"next": "/api/comparisons/v1?page=68",
"request_id": "zW3gfjjSHDgzNsxO"
}ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
NCBI Gene
One gene with its proteins, patents, drugs, trials, grants and papers.
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
Patent publications
Paste a sequence and see the patents that disclose it.
For invited accounts.
Opens sequences.conductscience.org
For software
Every answer on this page is also JSON, under /api/comparisons/v1. No key.
GET https://conductscience.org/api/comparisons/v1?q=placebo%20heart%20failure&kind=outcome
Ask an assistant